MedPath

GLENMARK PHARMACEUTICALS SINGAPORE PTE. LTD.

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

HSA:8

Drug Approvals

DOCEHOPE Concentrate for Solution for Infusion 20 mg/ ml

Approval Date
Feb 7, 2024
HSA

DOCEHOPE Concentrate for Solution for Infusion 80 mg/ 4 ml

Approval Date
Feb 7, 2024
HSA

ARABITRO ABIRATERONE ACETATE TABLET USP 250 mg

Approval Date
Mar 14, 2023
HSA

GLENDES TABLET 5 mg

Approval Date
Jan 5, 2023
HSA

ETOHOPE FILM-COATED TABLET 90 mg

Approval Date
Jun 20, 2022
HSA

ETOHOPE FILM-COATED TABLET 120 mg

Approval Date
Jun 20, 2022
HSA

ETOHOPE FILM-COATED TABLET 60 mg

Approval Date
Jun 20, 2022
HSA

EZZICAD TABLETS 10MG

Approval Date
Feb 18, 2022
HSA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.